Follow
Daniela Amaral Silva
Daniela Amaral Silva
Unknown affiliation
Verified email at ualberta.ca
Title
Cited by
Cited by
Year
Simulated, biorelevant, clinically relevant or physiologically relevant dissolution media: The hidden role of bicarbonate buffer
DA Silva, J Al-Gousous, NM Davies, NB Chacra, GK Webster, E Lipka, ...
European Journal of Pharmaceutics and Biopharmaceutics 142, 8-19, 2019
592019
The significance of disintegration testing in pharmaceutical development
DA Silva, GK Webster, N Bou-Chacra, R Löbenberg
Dissolution Technol 25 (3), 30-8, 2018
412018
Biphasic dissolution as an exploratory method during early drug product development
D Amaral Silva, J Al-Gousous, NM Davies, N Bou Chacra, GK Webster, ...
Pharmaceutics 12 (5), 420, 2020
232020
Phytocannabinoid drug-drug interactions and their clinical implications
DA Silva, DW Pate, RD Clark, NM Davies, AOS El-Kadi, R Löbenberg
Pharmacology & Therapeutics 215, 107621, 2020
212020
In silico prediction of plasma concentrations of fluconazole capsules with different dissolution profiles and bioequivalence study using population simulation
MD Duque, DA Silva, MG Issa, V Porta, R Löbenberg, HG Ferraz
Pharmaceutics 11 (5), 215, 2019
192019
Are excipients inert? Phenytoin pharmaceutical investigations with new incompatibility insights
DA Silva, R Löbenberg, N Davies
Journal of Pharmacy & Pharmaceutical Sciences 21 (1s), 19s-31s, 2018
152018
The lymphatic system: A sometimes-forgotten compartment in pharmaceutical sciences
M Yousef, D Silva, NB Chacra, N Davies, R Löbenberg
Journal of Pharmacy & Pharmaceutical Sciences 24, 533-547, 2021
122021
Mechanistic understanding of underperforming enteric coated products: Opportunities to add clinical relevance to the dissolution test
DA Silva, NM Davies, MR Doschak, J Al-Gousous, N Bou-Chacra, ...
Journal of controlled release 325, 323-334, 2020
122020
Application of in Silico Tools in Clinical Practice using Ketoconazole as a Model Drug.
DA Silva, MD Duque, NM Davies, R Löbenberg, HG Ferraz
Journal of pharmacy & pharmaceutical sciences: a publication of the Canadian …, 2018
112018
Intrinsic dissolution simulation of highly and poorly soluble drugs for BCS solubility classification
MD Duque, MG Issa, DA Silva, BAS Kakuda, LNC Rodrigues, ...
Dissolution Technol 24 (4), 6-11, 2017
112017
In silico Tools at Early Stage of Pharmaceutical Development: Data Needs and Software Capabilities
JO Njoku, D Amaral Silva, D Mukherjee, GK Webster, R Löbenberg
AAPS PharmSciTech 20, 1-10, 2019
72019
In silico simulation of dissolution profiles for development of extended-release doxazosin tablets
MD Duque, MG Issa, DA Silva, EJ Barbosa, R Löbenberg, HG Ferraz
Dissolution Technologies 25 (4), 14-21, 2018
62018
Physiologically relevant dissolution conditions towards improved in vitro-in vivo relationship–A case study with enteric coated pantoprazole tablets
DA Silva, MG Davanço, NM Davies, J Krämer, P de Oliveira Carvalho, ...
International Journal of Pharmaceutics 605, 120857, 2021
52021
Update on gastrointestinal biorelevant media and physiologically relevant dissolution conditions
DA Silva, NM Davies, N Bou-Chacra, HG Ferraz, R Löbenberg
Dissolution Technology 29, 62-75, 2022
32022
In Vitro Evaluation of a Foamable Microemulsion Towards an Improved Topical Delivery of Diclofenac Sodium
B Hajjar, J Zuo, C Park, S Azarmi, DA Silva, NA Bou-Chacra, ...
AAPS PharmSciTech 23 (4), 102, 2022
32022
Using GastroPlus to teach complex biopharmaceutical concepts
DA Silva, MK Cor, A Lavasanifar, NM Davies, R Löbenberg
Pharmacy Education 22 (1), 336-347, 2022
22022
In vitro study of a foamable microemulsion for improved topical delivery of diclofenac sodium*.
B Hajjar, J Zuo, C Park, S Azarmi, DA Silva, NA Bou-Chacra, ...
Abstracts, 2022
2022
A BCS-Based Biowaiver Approach Using Biphasic Dissolution Test
DA Silva, KJC Melo, NM Davies, N Bou-Chacra, HG Ferraz, R Löbenberg
Dissolution Technologies 28 (4), 40-48, 2021
2021
Novel biopharmaceutical development investigations towards drug and formulation performance optimization
DA Silva
Universidade de São Paulo, 2021
2021
Novel Biopharmaceutical Development Investigations Towards Drug and Formulation Performance Optimization
D Amaral Silva
2021
The system can't perform the operation now. Try again later.
Articles 1–20